Výsledky vyhledávání

Patients’ Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire

Autor: Clifton Blackwood, Arun Singh, Panna Sanga, Alexander Keenan, Srihari Gopal, Isaac Nuamah, Maju Mathews

Publikováno v: Patient preference and adherence

Introduction Understanding patients' preferences for long-acting injectable (LAI) or oral antipsychotics (pills) could help reduce potential barriers to LAI use in schizophrenia. Methods Post hoc analyses were conducted from a double-blind, randomize

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a98398a9d1c885e5228f3208e785e464
https://doi.org/10.2147/ppa.s251812

Zobrazit plný text záznamu

Vivacity MG Phase 3 Study: Clinical Trial of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Autor: Sindhu Ramchandren, Panna Sanga, Michel Burcklen, Hong Sun

Publikováno v: Neurology. 99:S41.2-S41

ObjectiveWe describe Vivacity-MG3. our pivotal Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Nipocalimab Administered to Adults With gMG

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::706a4ce0b9d0fa60d70ad03417a5382f
https://doi.org/10.1212/01.wnl.0000903328.46907.49

Zobrazit plný text záznamu

A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia

Autor: Raja Venkatasubramanian, Srihari Gopal, Steven Wang, Ruth Milz, Pilar Lim, David P Walling, Mary Jane Robertson, Dean Najarian, Kristin Cohen, Alain Schotte, Silvana Galderisi, Panna Sanga, Arun Singh, Huybrecht T'jollyn

Publikováno v: The international journal of neuropsychopharmacology. 25(3)

Background This double-blind (DB), randomized, parallel-group study was designed to evaluate efficacy and safety of paliperidone palmitate 6-month (PP6M) formulation relative to paliperidone palmitate 3-month (PP3M) formulation in patients with schiz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f5d242795e4af4361ee1e6dd3137ab8
https://pubmed.ncbi.nlm.nih.gov/34791283

Zobrazit plný text záznamu

Fulranumab as Adjunctive Therapy for Cancer-Related Pain: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

Autor: John Louie, Naim Zaki, Kathleen Kelly, Neal E Slatkin, Steven Wang, Panna Sanga, John Thipphawong

Publikováno v: The Journal of Pain. 20:440-452

This randomized, double-blind (DB), placebo-controlled, phase 2 study assessed the efficacy and safety of fulranumab as a pain therapy adjunctive to opioids in terminally ill cancer patients. Ninety-eight patients were randomized (2:1) to receive one

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0206fe92cb07ff4c50557ecec528c66d
https://doi.org/10.1016/j.jpain.2018.09.014

Zobrazit plný text záznamu

Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ-39439335) Tablet and Capsule Formulations in Healthy Men: Two Open-Label, Crossover, Single-Dose Phase 1 Studies

Autor: Joseph Caruso, Prasarn Manitpisitkul, Lucille Russell, Kevin Shalayda, Panna Sanga, John A. Moyer, Bhavna Solanki, Yinka Williams

Publikováno v: Clinical Pharmacology in Drug Development. 7:699-711

To improve room temperature stability and oral bioavailability of mavatrep (JNJ-39439335, a transient receptor potential vanilloid subtype-1 antagonist), various formulations were initially developed and evaluated in 2 phase 1 open-label, randomized,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::191819b167cde1d3331c1c34d950c2dc
https://doi.org/10.1002/cpdd.412

Zobrazit plný text záznamu

Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy

Autor: Hao Wang, John Thipphawong, Panna Sanga, Mary Ellen Frustaci, Margaret Fedgchin, Gary Romano, Kathleen Kelly, Lucille Russell

Publikováno v: The Clinical Journal of Pain. 33:99-108

Objective Fulranumab is an antibody that specifically neutralizes the biological activity of human nerve growth factor. This multicenter, phase-2, randomized, double-blind (DB), placebo-controlled study evaluated the analgesic efficacy and safety of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2040538bdee85d6177229b40b249d37
https://doi.org/10.1097/ajp.0000000000000388

Zobrazit plný text záznamu

S208. COMPARISON OF MEDICATION PREFERENCE FOR LONG-ACTING INJECTABLE VERSUS ORAL ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA: ANALYSIS OF A PATIENT-REPORTED QUESTIONNAIRE FROM A DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY

Autor: Arun Singh, Alexander Keenan, Panna Sanga, Srihari Gopal, Isaac Nuamah, Maju Mathews, Clifton Blackwood

Publikováno v: Schizophrenia Bulletin

Background There is limited information on patient’s perspective on choice of long-acting injectable (LAIs) or oral antipsychotic pills used in the management of schizophrenia. Assessing factors that determine patients’ preferences for LAI or ora

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a365b7dc6f1980067dd76b6c7872507f
http://europepmc.org/articles/PMC7234552

Zobrazit plný text záznamu

Safety and efficacy of fulranumab in osteoarthritis of the hip and knee: results from four early terminated phase III randomized studies

Autor: Steven Wang, John Thipphawong, Juergen Haeussler, John Louie, Panna Sanga, Naim Zaki, Kathleen Kelly

Objective: To evaluate the safety and efficacy of fulranumab as adjunct or monotherapy in patients with knee or hip pain related to moderate-to-severe osteoarthritis. Methods: Osteoarthritic patients (aged ≥18 years) from four phase 3 randomized, d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb682eb2e402debc4db302c67a3dc385

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání